142 related articles for article (PubMed ID: 20683817)
1. Chemoembolic lobectomy: imaging findings of hepatic lobar volume reduction after transcatheter arterial chemoembolization.
Gaba RC; Carroll JJ; Bui JT; Carrillo TC; Knuttinen MG; Owens CA
Diagn Interv Radiol; 2011 Jun; 17(2):177-80. PubMed ID: 20683817
[TBL] [Abstract][Full Text] [Related]
2. Locoregional chemoembolic delivery: prediction with transcatheter intraarterial perfusion MRI.
Gaba RC; Jin B; Wang D; Lewandowski RJ; Ragin AB; Larson AC; Salem R; Omary RA
AJR Am J Roentgenol; 2012 May; 198(5):1196-202. PubMed ID: 22528913
[TBL] [Abstract][Full Text] [Related]
3. Transcatheter arterial chemoembolization of hepatocellular carcinoma: a Japanese experience.
Higashihara H; Okazaki M
Hepatogastroenterology; 2002; 49(43):72-8. PubMed ID: 11941988
[TBL] [Abstract][Full Text] [Related]
4. Prospective evaluation of transcatheter arterial chemoembolization (TACE) with multiple anti-cancer drugs (epirubicin, cisplatin, mitomycin c, 5-fluorouracil) compared with TACE with epirubicin for treatment of hepatocellular carcinoma.
Sahara S; Kawai N; Sato M; Tanaka T; Ikoma A; Nakata K; Sanda H; Minamiguchi H; Nakai M; Shirai S; Sonomura T
Cardiovasc Intervent Radiol; 2012 Dec; 35(6):1363-71. PubMed ID: 22358993
[TBL] [Abstract][Full Text] [Related]
5. Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center.
Vogl TJ; Trapp M; Schroeder H; Mack M; Schuster A; Schmitt J; Neuhaus P; Felix R
Radiology; 2000 Feb; 214(2):349-57. PubMed ID: 10671580
[TBL] [Abstract][Full Text] [Related]
6. Chemoembolization as a bridge to transplantation for hepatocellular carcinoma.
Gores GJ
Liver Transpl; 2001 Nov; 7(11):998. PubMed ID: 11699037
[No Abstract] [Full Text] [Related]
7. Transcatheter arterial infusion chemotherapy with a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma refractory to transcatheter arterial chemoembolization.
Iwasa S; Ikeda M; Okusaka T; Ueno H; Morizane C; Nakachi K; Mitsunaga S; Kondo S; Hagihara A; Shimizu S; Satake M; Arai Y
Jpn J Clin Oncol; 2011 Jun; 41(6):770-5. PubMed ID: 21459893
[TBL] [Abstract][Full Text] [Related]
8. Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization.
Sumie S; Yamashita F; Ando E; Tanaka M; Yano Y; Fukumori K; Sata M
AJR Am J Roentgenol; 2003 Nov; 181(5):1327-34. PubMed ID: 14573429
[TBL] [Abstract][Full Text] [Related]
9. Enhancement patterns of hepatocellular carcinoma after transarterial chemoembolization using drug-eluting beads on arterial phase CT images: a pilot retrospective study.
Chung WS; Lee KH; Park MS; Lee YJ; Kwon J; Baek SE; Kim MJ
AJR Am J Roentgenol; 2012 Aug; 199(2):349-59. PubMed ID: 22826396
[TBL] [Abstract][Full Text] [Related]
10. A patient with a large hepatocellular carcinoma alive 13 years after repeated transcatheter arterial chemoembolization and hepatectomy.
Asahara T; Dohi K; Nakahara H; Katayama K; Itamoto T; Sugino K; Ono E; Ito K; Azuma K; Shimamoto F
Hiroshima J Med Sci; 1999 Mar; 48(1):41-4. PubMed ID: 10213963
[TBL] [Abstract][Full Text] [Related]
11. Transcatheter arterial chemoembolization with doxorubicin-eluting superabsorbent polymer microspheres in the treatment of hepatocellular carcinoma: midterm follow-up.
Dekervel J; van Malenstein H; Vandecaveye V; Nevens F; van Pelt J; Heye S; Laleman W; Van Steenbergen W; Vaninbroukx J; Verslype C; Maleux G
J Vasc Interv Radiol; 2014 Feb; 25(2):248-55.e1. PubMed ID: 24295569
[TBL] [Abstract][Full Text] [Related]
12. Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents.
Brown DB; Pilgram TK; Darcy MD; Fundakowski CE; Lisker-Melman M; Chapman WC; Crippin JS
J Vasc Interv Radiol; 2005 Dec; 16(12):1661-6. PubMed ID: 16371533
[TBL] [Abstract][Full Text] [Related]
13. [Transcatheter arterial chemoembolization with doxorubicin eluting beads in the treatment of hepatocellular carcinoma].
Sousa PF; Preto AS; Leão D; Madureira AM; Paquete J; Costa-Maia J; Vilares-Morgado P
Acta Med Port; 2011; 24(1):29-36. PubMed ID: 21672439
[TBL] [Abstract][Full Text] [Related]
14. Transcatheter arterial embolic therapies for hepatocellular carcinoma: a literature review.
Nishikawa H; Kita R; Kimura T; Osaki Y
Anticancer Res; 2014 Dec; 34(12):6877-86. PubMed ID: 25503113
[TBL] [Abstract][Full Text] [Related]
15. Treatment of hepatocellular carcinoma using arterial chemoembolization with degradable starch microspheres and continuous arterial infusion of 5-fluorouracil.
Ishida K; Hirooka M; Hiraoka A; Kumagi T; Uehara T; Hiasa Y; Horiike N; Onji M
Jpn J Clin Oncol; 2008 Sep; 38(9):596-603. PubMed ID: 18772170
[TBL] [Abstract][Full Text] [Related]
16. Conventional versus doxorubicin-eluting bead transarterial chemoembolization for hepatocellular carcinoma.
Sacco R; Bargellini I; Bertini M; Bozzi E; Romano A; Petruzzi P; Tumino E; Ginanni B; Federici G; Cioni R; Metrangolo S; Bertoni M; Bresci G; Parisi G; Altomare E; Capria A; Bartolozzi C
J Vasc Interv Radiol; 2011 Nov; 22(11):1545-52. PubMed ID: 21849247
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for the leakage of chemotherapeutic agents into systemic circulation after transcatheter arterial chemoembolization of hepatocellular carcinoma.
Hsieh MY; Lin ZY; Chen SH; Chuang WL
Kaohsiung J Med Sci; 2011 Oct; 27(10):431-6. PubMed ID: 21943814
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of arterial phase CT for prediction of response to transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma: a retrospective analysis.
Katyal S; Oliver JH; Peterson MS; Chang PJ; Baron RL; Carr BI
AJR Am J Roentgenol; 2000 Dec; 175(6):1665-72. PubMed ID: 11090401
[TBL] [Abstract][Full Text] [Related]
19. Three-Dimensional Quantitative Color-Coding Analysis of Hepatic Arterial Flow Change during Chemoembolization of Hepatocellular Carcinoma.
Lin EY; Lee RC; Guo WY; Wu FC; Gehrisch S; Kowarschik M
J Vasc Interv Radiol; 2018 Oct; 29(10):1362-1368. PubMed ID: 30170947
[TBL] [Abstract][Full Text] [Related]
20. Multimodality management of hepatocellular carcinoma larger than 10 cm.
Mok KT; Wang BW; Lo GH; Liang HL; Liu SI; Chou NH; Tsai CC; Chen IS; Yeh MH; Chen YC
J Am Coll Surg; 2003 Nov; 197(5):730-8. PubMed ID: 14585406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
